About Us

Sonoran Biosciences is a privately held specialty pharmaceutical company developing extended-release formulations for the treatment of postoperative pain and surgical site infection (SSI). Sonoran’s products are based on its patented platform technology SB Gel, an injectable carrier that forms a solid gel in the body, releases drugs over multiple days, and dissolves after the time required for complete drug release. Sonoran’s lead products are SBG004, an extended-release formulation of bupivacaine for acute postoperative pain, and SBG003, a fixed-dose combination of tobramycin and vancomycin for SSI.